BLT 0.00% 2.6¢ benitec biopharma limited

Is BLT next?, page-5

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    Impossible to say. Novartis was already in that space. All they have done is buy a competitor.

    I am not aware of any big pharma working in the OPMD space. I think we have no competition, which is both a pro and a con. If get through our trial successfully, I can see interest heating up but that is some way off.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.